PAF-acether (Platelet Activating Factor)

  • B. Arnoux
  • C. Brink
  • J. Benveniste


When basophils, which were derived from sensitized rabbits, were challenged with a specific allergen a substance was extracted which was capable of aggregating rabbit platelets [3]. Since its initial detection it has been referred to as platelet activating factor (PAF), and more recently acetyl-glyceryl-ether-phosphorylcholine (AGEPC) or PAF-acether. The detection of this ubiquitous compound when various cells or organs are appropriately challenged has led to its acceptance as a pivotal molecule in a variety of pathophysiological conditions.


Lipase Aspirin Choline Thrombin Creatine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albert DH, Snyder F (1983) Biosynthesis of 1 -alkyl-2-acetyl-sfl -glycero-phosphocholine by rat alveolar macrophages. J Biol Chem 258: 97–102PubMedGoogle Scholar
  2. 2.
    Alonso F, Garcia Gil M, Sanchez-Crespo M, Mato JM (1982) Activation of l-alkyl-2-lyso-glycero-3-phosphocholine: acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J Biol Chem 257: 3376–3378PubMedGoogle Scholar
  3. 3.
    Archer CB, Page CP, Paul W, Morley J, McDonald DM (1984) Inflammatory characteristics of platelet-activating factor ( PAF- acether) in human skin. Br J Dermatol 110: 45–50Google Scholar
  4. 4.
    Arnoux B, Simoes-Caeiro MH, Landes A, Mathieu M, Duroux P, Benveniste J (1982) Alveolar macrophages from asthmatic patients release platelet-activating factor (PAF- acether) and lyso PAF-acether when stimulated with the specific allergen. Am Rev Re-spir Dis 125: 70 (abstract)Google Scholar
  5. 5.
    Arnoux B, Duval D, Benveniste J (1980) Release of platelet-activating (PAF) from alveolar macrophages by calcium ionophore A 23187 and phagocytosis. Eur J Clin Invest 10: 437–441PubMedCrossRefGoogle Scholar
  6. 6.
    Benveniste J, Boullet C, Brink C, Labat C (1983) The actions of PAF-acether (platelet-activating factor) on guinea pig-isolated heart preparations. Br J Pharmacol 80: 81–83PubMedGoogle Scholar
  7. 7.
    Benveniste J, Chignard M, Le Couedic JP, Vargaftig BB (1982) Biosynthesis of platelet-activating factor (PAF-acether). II. Involvement of phospholipase A2 in the formation of PAF-acether and lyso-PAF-acether from rabbit platelets. Thromb Res 25: 375–386PubMedCrossRefGoogle Scholar
  8. 8.
    Benveniste J, Henson PM, Cochrane CG (1972) Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils and a platelet-activating factor. J Exp Med 136: 1356–1377PubMedCrossRefGoogle Scholar
  9. 9.
    Benveniste J, Le Couedic JP, Polonsky J, Tencé M (1977) Structural analysis of purified platelet-activating factor by lipases. Nature 269: 170–171PubMedCrossRefGoogle Scholar
  10. 10.
    Benveniste J, Tencé M, Varenne P, Bidault J, Boullet C, Polonsky J (1979) Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acéther, un alkyl éther analogue de la lysophosphatidylcho-line. CR Acad Se Paris 289D: 1037–1040Google Scholar
  11. 11.
    Bessin P, Bonnet J, Apffel D, Soulard C, Desgroux L, Pelas I, Benveniste J (1983) Acute circulatory collapse caused by platelet-activating factor ( PAF-acether) in dogs. Eur J Pharmacol 86: 403–413Google Scholar
  12. 12.
    Betz SJ, Lotner GZ, Henson PM (1980) Generation and release of platelet-activating factor ( PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF. J Immunol 125: 2749–2755Google Scholar
  13. 13.
    Bjôrk J, Smedegard G (1983) Acute microvascular effects of PAF-acether, as studied by intravital microscopy. Eur J Pharmacol 96: 87–94PubMedCrossRefGoogle Scholar
  14. 14.
    Blank ML, Snyder F, Byers LW, Brooks B, Muirhead EE (1979) Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun 90: 1194–1200PubMedCrossRefGoogle Scholar
  15. 15.
    Bonnet J, Loiseau AM, Orvaen M, Bessin P (1981) Platelet-activating factor (PAF- acether) involvement in acute inflammatory and pain process. In: Russo-Marie F, Vargaftig BB, Benveniste J (eds) Pharmacology of Inflammation and Allergy: Lipids and Cells, vol. 100. INSERM, Paris, pp 111–118Google Scholar
  16. 16.
    Bonnet J, Thibaudeau D, Bessin P (1983) Dependency of the PAF-acether-induced bronchospasm on the lipoxygenase pathway in the guinea-pig. Prostaglandins 26: 457–466PubMedCrossRefGoogle Scholar
  17. 17.
    Caillard CC, Mondot S, Julou L (1981) Action hypotensive du PAF-acether chez le rat. J Pharmacol 12: 301 (abstract)Google Scholar
  18. 18.
    Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C (1981) Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 42: 191–199PubMedGoogle Scholar
  19. 19.
    Camussi G, Tetta C, Bussolino F, Caligaris Cappio F, Coda R, Masera C, Segoloni G (1981) Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol 64: 25–41Google Scholar
  20. 20.
    Cerrina J, Raffestin B, Labat C, Boullet C, Bayol A, Gateau O, Brink C (1983) Effects of PAF-acether on isolated muscle preparations from the rat, guinea pig and human lung. In: Benveniste J, Arnoux B (eds) Platelet-Activating Factor and Structurally-Related Ether Lipids. Elsevier, Amsterdam, pp 205–212 (INSERM Symposium no. 23 )Google Scholar
  21. 21.
    Chignard M, Le Couedic JP, Tence M, Vargaftig BB, Benveniste J (1979) The role of platelet-activating factor in platelet aggregation. Nature 279: 799–800PubMedCrossRefGoogle Scholar
  22. 22.
    Czarnetzki MB, Benveniste J (1981) Effect of 1–0-octadecyl-2–0-acetyl-5?7 -glycero-3-phos-phorylcholine (PAF-acether) on leukocytes. I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids 29: 317–326Google Scholar
  23. 23.
    Demopoulos CA, Pinckard RN, Hanahan DJ (1979) Platelet-activating factor. Evidence for l-0-alkyl-2-acetyl-s«-glyceryl- 3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 254: 9355–9358PubMedGoogle Scholar
  24. 24.
    Denjean A, Arnoux B, Masse R, Lockhart A, Benveniste J (1983) Acute effect of intratracheal administration of PAF-acether in baboons. J Appl Physiol 55: 799–804PubMedGoogle Scholar
  25. 25.
    Feuerstein G, Boyd LM, Ezra D, Goldstein RE (1984) Effect of platelet-activating factor on coronary circulation of the domestic pig. Am J Physiol 246: H466–H471PubMedGoogle Scholar
  26. 26.
    Gateau O, Arnoux B, Deriaz H, Benveniste J (1984) Acute effects of intratracheal administration of PAF-acether (platelet-activating factor) in humans. Am Rev Respir Dis 129: A3 (abstract)Google Scholar
  27. 27.
    Godfroid JJ, Heymans F, Michel E, Redeuilh C, Steiner E, Benveniste J (1980) Platelet-activating factor (PAF-acether): total synthesis of l-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine. FEBS Lett 116: 161–164PubMedCrossRefGoogle Scholar
  28. 28.
    Joseph M, Tonnel AB, Torpier G, Capron A, Arnoux B, Benveniste J (1983) The involvement of IgG in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest 71: 221–230PubMedCrossRefGoogle Scholar
  29. 29.
    Lee T-C, Malone B, Wasserman SI, Fitzgerald V, Snyder F (1982) Activities of enzymes that metabolize platelet-activating factor (1 -alkyl-2-acetyl-sn-glycero-3-phos-phocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun 105: 1303–1308PubMedCrossRefGoogle Scholar
  30. 30.
    Lotner GZ, Lynch JM, Betz SJ, Henson PM (1980) Human neutrophil-derived platelet-activating factor. J Immunol 124: 676–684PubMedGoogle Scholar
  31. 31.
    McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN (1980) Pathobiology of the intravenous infusion of acetyl-glyceryl-ether-phosphorylcholine (AGEPC), a synthetic platelet-activating factor ( PAF) in the rabbit. J Immunol 124: 2919–2924Google Scholar
  32. 32.
    Mencia-Huerta JM, Benveniste J (1979) Platelet-activating factor (PAF) and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 9: 409–415Google Scholar
  33. 33.
    Muirhead EE, Stirman JA (1958) Dietary protein and hypertension in the dog: protection by ureterocaval anastomosis with a study of the kidneys so treated. Am J Pathol 34: 561 (abstract)Google Scholar
  34. 34.
    Namm DH, Tadepalli AS, High JA (1982) Species specificity of the platelet responses to l-0-alkyl-2-acetyl-glycero-3-phosphocho-line. Thromb Res 25: 341–350PubMedCrossRefGoogle Scholar
  35. 35.
    Ninio E, Mencia-Huerta JM, Heymans F, Benveniste J (1982) Biosynthesis of platelet-activating factor (PAF-acether). I. Evidence for an acetyltransferase activity in murine macrophages. Biochim Biophys Acta 710: 23–31Google Scholar
  36. 36.
    O’Flaherty JT, Wykle RL, Miller CH, Lewis JC, Waite M, Bass DA, McCall MD, de- Chatelet LR (1981) 1-O-alkyl-glyceryl- 3-phosphorylcholines. A novel class of neutrophil stimulants. Am J Pathol 103: 70–78Google Scholar
  37. 37.
    Page CP, Paul W, Douglas GJ, Casals-Sten-zel J, Morley J (1983) PAF-acether, platelets and bronchospasm. In: Benveniste J, Arnoux B (eds) Platelet-Activating Factor and Structurally-Related Ether-Lipids. Elsevier, Amsterdam, pp 327–334 (INSERM Symposium no. 23 )Google Scholar
  38. 38.
    Patterson R, Harris KE (1983) The activity of aerosolized and intracutaneous synthetic platelet-activating factor ( AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. J Lab Clin Med 102: 933–938Google Scholar
  39. 39.
    Pinckard RN, Kniker WT, Lee L, Hanahan DJ, McManus LM (1980) Vasoactive properties of l-0-alkyl-2-acetyl-rn-glyceryl-3-phos-phocholine (AcGEPC) in human skin. J Allergy Clin Immunol 63: 196 (abstract)Google Scholar
  40. 40.
    Pirotzky E, Page CP, Roubin R, Pfister A, Paul W, Bonnet J, Benveniste J (1984) PAF- acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. Microcirc Endothel Lymph 1: 107–122Google Scholar
  41. 41.
    Poitevin B, Roubin R, Benveniste J (1984) PAF-acether generates chemiluminescence in human neutrophils in the absence of cy-tochalasin B. Immunopharmacology 7: 135–144PubMedCrossRefGoogle Scholar
  42. 42.
    Prancan A, Lefort J, Barton M, Vargaftig BB (1982) Relaxation of the guinea pig trachea induced by platelet-activating factor and by serotonin. Eur J Pharmacol 80: 29–35PubMedCrossRefGoogle Scholar
  43. 43.
    Roubin R, Tencé M, Mencia-Huerta JM, Arnoux B, Ninio E, Benveniste J (1983) A chemically defined monokine-macrophage-defined platelet-activating factor. In: Pick E (ed) Lymphokines, vol. 8. Academic Press, New York, pp 249–276Google Scholar
  44. 44.
    Santamaria R, Pourrias B, Benveniste J (1983) Effet du PAF-acéther sur la veine porte de rat. J Pharmacol 14 [Suppl]: 83 (abstract)Google Scholar
  45. 45.
    Stimler NP, Bloor CM, Hugli TE, Wykle RL, McCall CE, O’Flaherty JT (1981) Anaphylactic actions of platelet-activating factor. Am J Pathol 105: 64–69PubMedGoogle Scholar
  46. 46.
    Vargaftig BB, Lefort J, Chignard M, Benveniste J (1980) Platelet-activating factor induces a platelet-dependent bronchoconstric-tion unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 65: 185–192PubMedCrossRefGoogle Scholar
  47. 47.
    Vargaftig B, Lefort J, Rotilio D (1983) Route-dependent interactions between PAF- acether and guinea-pig bronchopulmonary smooth muscle: relevance of cyclooxygenase mechanism. In: Benveniste J, Arnoux B (eds) Platelet-Activating Factor and Struc-turally-Related Ether-Lipids. Elsevier, Amsterdam, pp 307–316 (INSERM Symposium no. 23 )Google Scholar
  48. 48.
    Wykle RL, Malone B, Snyder F (1980) Enzymatic synthesis of l-alkyl-2-acetyl-sn- glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. J Biol Chem 255: 10256–10260PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1987

Authors and Affiliations

  • B. Arnoux
  • C. Brink
  • J. Benveniste

There are no affiliations available

Personalised recommendations